JP Patent

JP7213854B2 — 化学療法の間の正常細胞の一時的な保護

Assigned to G1 Therapeutics Inc · Expires 2023-01-27 · 3y expired

What this patent protects

Patent listed against trilaciclib-dihydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP7213854B2
Jurisdiction
JP
Classification
—
Expires
2023-01-27
Drug substance claim
No
Drug product claim
No
Assignee
G1 Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.